Page last updated: 2024-10-25

eflornithine and Helicobacter Infections

eflornithine has been researched along with Helicobacter Infections in 2 studies

Eflornithine: An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway.
eflornithine : A fluoroamino acid that is ornithine substituted by a difluoromethyl group at position 2.

Helicobacter Infections: Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wilson, KT2
Barry, DP1
Asim, M1
Leiman, DA1
de Sablet, T1
Singh, K1
Casero, RA1
Chaturvedi, R1

Other Studies

2 other studies available for eflornithine and Helicobacter Infections

ArticleYear
Preventing Gastric Cancer Development by Inhibiting the Virulence of H. pylori Infection.
    Oncology (Williston Park, N.Y.), 2019, 06-19, Volume: 33, Issue:6

    Topics: Antineoplastic Agents; Eflornithine; Helicobacter Infections; Helicobacter pylori; Humans; Stomach N

2019
Difluoromethylornithine is a novel inhibitor of Helicobacter pylori growth, CagA translocation, and interleukin-8 induction.
    PloS one, 2011, Feb-28, Volume: 6, Issue:2

    Topics: Animals; Antigens, Bacterial; Bacterial Proteins; Cells, Cultured; Eflornithine; Enzyme Inhibitors;

2011